215 related articles for article (PubMed ID: 32347983)
1. Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug-Naive Parkinson's Disease.
Wilson H; Pagano G; de Natale ER; Mansur A; Caminiti SP; Polychronis S; Middleton LT; Price G; Schmidt KF; Gunn RN; Rabiner EA; Politis M
Mov Disord; 2020 Aug; 35(8):1416-1427. PubMed ID: 32347983
[TBL] [Abstract][Full Text] [Related]
2. Characterization of 3 PET Tracers for Quantification of Mitochondrial and Synaptic Function in Healthy Human Brain:
Mansur A; Rabiner EA; Comley RA; Lewis Y; Middleton LT; Huiban M; Passchier J; Tsukada H; Gunn RN;
J Nucl Med; 2020 Jan; 61(1):96-103. PubMed ID: 31324712
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal Positron Emission Tomography Imaging of Presynaptic Terminals in Early Parkinson's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2022 Sep; 37(9):1883-1892. PubMed ID: 35819412
[TBL] [Abstract][Full Text] [Related]
4. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.
Delva A; Van Laere K; Vandenberghe W
Mov Disord; 2023 Aug; 38(8):1515-1526. PubMed ID: 37382295
[TBL] [Abstract][Full Text] [Related]
6. Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease.
Delva A; Van Weehaeghe D; Koole M; Van Laere K; Vandenberghe W
Mov Disord; 2020 Nov; 35(11):1977-1986. PubMed ID: 32767618
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of synaptic density with [
Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal Synaptic Loss in Primary Tauopathies: An In Vivo [
Holland N; Jones PS; Savulich G; Naessens M; Malpetti M; Whiteside DJ; Street D; Swann P; Hong YT; Fryer TD; Rittman T; Mulroy E; Aigbirhio FI; Bhatia KP; O'Brien JT; Rowe JB
Mov Disord; 2023 Jul; 38(7):1316-1326. PubMed ID: 37171832
[TBL] [Abstract][Full Text] [Related]
9. Mild Motor Signs in Healthy Aging Are Associated with Lower Synaptic Density in the Brain.
Van Cauwenberge MGA; Delva A; Vande Casteele T; Laroy M; Radwan A; Vansteelandt K; Van den Stock J; Bouckaert F; Van Laere K; Emsell L; Vandenberghe W; Vandenbulcke M
Mov Disord; 2023 Oct; 38(10):1786-1794. PubMed ID: 37574924
[TBL] [Abstract][Full Text] [Related]
10. Synaptic loss and its association with symptom severity in Parkinson's disease.
Holmes SE; Honhar P; Tinaz S; Naganawa M; Hilmer AT; Gallezot JD; Dias M; Yang Y; Toyonaga T; Esterlis I; Mecca A; Van Dyck C; Henry S; Ropchan J; Nabulsi N; Louis ED; Comley R; Finnema SJ; Carson RE; Matuskey D
NPJ Parkinsons Dis; 2024 Feb; 10(1):42. PubMed ID: 38402233
[TBL] [Abstract][Full Text] [Related]
11. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
Delva A; Michiels L; Koole M; Van Laere K; Vandenberghe W
Neurology; 2022 Jan; 98(1):e83-e94. PubMed ID: 34663644
[TBL] [Abstract][Full Text] [Related]
12. Synaptic Loss in Primary Tauopathies Revealed by [
Holland N; Jones PS; Savulich G; Wiggins JK; Hong YT; Fryer TD; Manavaki R; Sephton SM; Boros I; Malpetti M; Hezemans FH; Aigbirhio FI; Coles JP; O'Brien J; Rowe JB
Mov Disord; 2020 Oct; 35(10):1834-1842. PubMed ID: 32652635
[TBL] [Abstract][Full Text] [Related]
13. Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [
Andersen KB; Hansen AK; Schacht AC; Horsager J; Gottrup H; Klit H; Danielsen EH; Poston KL; Pavese N; Brooks DJ; Borghammer P
Mov Disord; 2023 May; 38(5):796-805. PubMed ID: 36905188
[TBL] [Abstract][Full Text] [Related]
14. Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease.
Chou KL; Dayalu P; Koeppe RA; Gilman S; Spears CC; Albin RL; Kotagal V
Mov Disord; 2022 Nov; 37(11):2301-2307. PubMed ID: 36102173
[TBL] [Abstract][Full Text] [Related]
15. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
[TBL] [Abstract][Full Text] [Related]
16. Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson's Disease.
Raval NR; Gudmundsen F; Juhl M; Andersen IV; Speth N; Videbæk A; Petersen IN; Mikkelsen JD; Fisher PM; Herth MM; Plavén-Sigray P; Knudsen GM; Palner M
Front Synaptic Neurosci; 2021; 13():715811. PubMed ID: 34867258
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
18. Four-Year Follow-up of [
Kogan RV; Janzen A; Meles SK; Sittig E; Renken RJ; Gurvits V; Mayer G; Leenders KL; Oertel WH;
Mov Disord; 2021 Jan; 36(1):230-235. PubMed ID: 32909650
[TBL] [Abstract][Full Text] [Related]
19. Brain and Systemic Inflammation in De Novo Parkinson's Disease.
Yacoubian TA; Fang YD; Gerstenecker A; Amara A; Stover N; Ruffrage L; Collette C; Kennedy R; Zhang Y; Hong H; Qin H; McConathy J; Benveniste EN; Standaert DG
Mov Disord; 2023 May; 38(5):743-754. PubMed ID: 36853618
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
Kremer T; Taylor KI; Siebourg-Polster J; Gerken T; Staempfli A; Czech C; Dukart J; Galasko D; Foroud T; Chahine LM; Coffey CS; Simuni T; Weintraub D; Seibyl J; Poston KL; Toga AW; Tanner CM; Marek K; Hutten SJ; Dziadek S; Trenkwalder C; Pagano G; Mollenhauer B
Mov Disord; 2021 Aug; 36(8):1972-1978. PubMed ID: 33942926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
